Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis.

Wu ES, Park JY, Zeitouni JA, Gomez CR, Reis IM, Zhao W, Kwon D, Lee E, Nelson OL, Lin HY, Franzmann EJ, Savell J, McCaffrey TV, Goodwin WJ, Hu JJ.

Head Neck. 2016 Aug;38(8):1234-41. doi: 10.1002/hed.24420. Epub 2016 Mar 29.

PMID:
27028310
2.

Risk Stratification System for Oral Cancer Screening.

Pereira LH, Reis IM, Reategui EP, Gordon C, Saint-Victor S, Duncan R, Gomez C, Bayers S, Fisher P, Perez A, Goodwin WJ, Hu JJ, Franzmann EJ.

Cancer Prev Res (Phila). 2016 Jun;9(6):445-55. doi: 10.1158/1940-6207.CAPR-15-0200. Epub 2016 Mar 28.

3.

Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trial.

Armstrong WB, Taylor TH, Kennedy AR, Melrose RJ, Messadi DV, Gu M, Le AD, Perloff M, Civantos F, Goodwin WJ, Wirth LJ, Kerr AR, Meyskens FL Jr.

Cancer Prev Res (Phila). 2013 May;6(5):410-8. doi: 10.1158/1940-6207.CAPR-13-0004.

4.

CD44 interacts with EGFR and promotes head and neck squamous cell carcinoma initiation and progression.

Perez A, Neskey DM, Wen J, Pereira L, Reategui EP, Goodwin WJ, Carraway KL, Franzmann EJ.

Oral Oncol. 2013 Apr;49(4):306-13. doi: 10.1016/j.oraloncology.2012.11.009. Epub 2012 Dec 20.

5.

Salivary protein and solCD44 levels as a potential screening tool for early detection of head and neck squamous cell carcinoma.

Franzmann EJ, Reategui EP, Pereira LH, Pedroso F, Joseph D, Allen GO, Hamilton K, Reis I, Duncan R, Goodwin WJ, Hu JJ, Lokeshwar VB.

Head Neck. 2012 May;34(5):687-95. doi: 10.1002/hed.21810. Epub 2011 Jul 11.

6.

Gastrostomy tube placement without nasogastric tube: a retrospective evaluation in 85 patients.

Heberlein WE, Goodwin WJ, Wood CE, Yousaf M, Culp WC.

Cardiovasc Intervent Radiol. 2012 Dec;35(6):1433-8. doi: 10.1007/s00270-011-0321-9. Epub 2011 Dec 8.

PMID:
22159959
7.

Perceived social support as a predictor of disease-specific quality of life in head-and-neck cancer patients.

Penedo FJ, Traeger L, Benedict C, Thomas G, Dahn JR, Krause MH, Goodwin WJ.

J Support Oncol. 2012 May-Jun;10(3):119-23. doi: 10.1016/j.suponc.2011.09.002. Epub 2011 Nov 16.

PMID:
22088826
8.

Salivary markers and risk factor data: a multivariate modeling approach for head and neck squamous cell carcinoma detection.

Pereira LH, Adebisi IN, Perez A, Wiebel M, Reis I, Duncan R, Goodwin WJ, Hu JJ, Lokeshwar VB, Franzmann EJ.

Cancer Biomark. 2011;10(5):241-9.

PMID:
22699785
9.

Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and Neck.

Nemunaitis J, Clayman G, Agarwala SS, Hrushesky W, Wells JR, Moore C, Hamm J, Yoo G, Baselga J, Murphy BA, Menander KA, Licato LL, Chada S, Gibbons RD, Olivier M, Hainaut P, Roth JA, Sobol RE, Goodwin WJ.

Clin Cancer Res. 2009 Dec 15;15(24):7719-7725.

10.

Alcohol and tobacco use prediagnosis and postdiagnosis, and survival in a cohort of patients with early stage cancers of the oral cavity, pharynx, and larynx.

Mayne ST, Cartmel B, Kirsh V, Goodwin WJ Jr.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3368-74. doi: 10.1158/1055-9965.EPI-09-0944.

11.

Intra-operative use of PET probe for localization of FDG avid lesions.

Molina MA, Goodwin WJ, Moffat FL, Serafini AN, Sfakianakis GN, Avisar E.

Cancer Imaging. 2009 Sep 29;9:59-62. doi: 10.1102/1470-7330.2009.0009.

12.

Impact of hospital volume on surgical outcome for head and neck cancer.

Cheung MC, Koniaris LG, Perez EA, Molina MA, Goodwin WJ, Salloum RM.

Ann Surg Oncol. 2009 Apr;16(4):1001-9. doi: 10.1245/s10434-008-0191-9. Epub 2008 Nov 4.

PMID:
18982393
13.

African American and poor patients have a dramatically worse prognosis for head and neck cancer: an examination of 20,915 patients.

Molina MA, Cheung MC, Perez EA, Byrne MM, Franceschi D, Moffat FL, Livingstone AS, Goodwin WJ, Gutierrez JC, Koniaris LG.

Cancer. 2008 Nov 15;113(10):2797-806. doi: 10.1002/cncr.23889.

14.

Management of the neck in Merkel cell carcinoma of the head and neck: University of Miami experience.

Shnayder Y, Weed DT, Arnold DJ, Gomez-Fernandez C, Bared A, Goodwin WJ, Civantos FJ.

Head Neck. 2008 Dec;30(12):1559-65. doi: 10.1002/hed.20899.

PMID:
18767173
15.

Unequal burden of head and neck cancer in the United States.

Goodwin WJ, Thomas GR, Parker DF, Joseph D, Levis S, Franzmann E, Anello C, Hu JJ.

Head Neck. 2008 Mar;30(3):358-71.

PMID:
17972309
16.

Soluble CD44 is a potential marker for the early detection of head and neck cancer.

Franzmann EJ, Reategui EP, Pedroso F, Pernas FG, Karakullukcu BM, Carraway KL, Hamilton K, Singal R, Goodwin WJ.

Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1348-55.

17.

Characterization of CD44v3-containing isoforms in head and neck cancer.

Reategui EP, de Mayolo AA, Das PM, Astor FC, Singal R, Hamilton KL, Goodwin WJ, Carraway KL, Franzmann EJ.

Cancer Biol Ther. 2006 Sep;5(9):1163-8. Epub 2006 Sep 11.

PMID:
16855392
18.
19.

Lymphatic mapping and sentinel lymphadenectomy for 106 head and neck lesions: contrasts between oral cavity and cutaneous malignancy.

Civantos FJ, Moffat FL, Goodwin WJ.

Laryngoscope. 2006 Mar;112(3 Pt 2 Suppl 109):1-15.

PMID:
16540925
20.

Primary carcinosarcoma of the helix of the ear.

Vincek V, Mirzabeigi M, Jewett BS, Goodwin WJ.

Ear Nose Throat J. 2005 Nov;84(11):712-5.

PMID:
16381134
21.

Salivary soluble CD44: a potential molecular marker for head and neck cancer.

Franzmann EJ, Reategui EP, Carraway KL, Hamilton KL, Weed DT, Goodwin WJ.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):735-9.

22.

Supplemental beta-carotene, smoking, and urinary F2-isoprostane excretion in patients with prior early stage head and neck cancer.

Mayne ST, Walter M, Cartmel B, Goodwin WJ Jr, Blumberg J.

Nutr Cancer. 2004;49(1):1-6. Erratum in: Nutr Cancer. 2004;49(2):223.

PMID:
15454352
23.

Treatment of recurrent and advanced stage squamous cell carcinoma of the head and neck.

Arnold DJ, Goodwin WJ, Weed DT, Civantos FJ.

Semin Radiat Oncol. 2004 Apr;14(2):190-5. Review.

PMID:
15095264
24.

MUC4 and ERBB2 expression in major and minor salivary gland mucoepidermoid carcinoma.

Weed DT, Gomez-Fernandez C, Pacheco J, Ruiz J, Hamilton-Nelson K, Arnold DJ, Civantos FJ, Zhang J, Yasin M, Goodwin WJ, Carraway KL.

Head Neck. 2004 Apr;26(4):353-64.

PMID:
15054739
25.

Low plasma lycopene concentration is associated with increased mortality in a cohort of patients with prior oral, pharynx or larynx cancers.

Mayne ST, Cartmel B, Lin H, Zheng T, Goodwin WJ Jr.

J Am Coll Nutr. 2004 Feb;23(1):34-42.

PMID:
14963051
26.

Does electron beam computer tomography provide added value in the diagnosis of coronary artery disease?

Fuseini M, Goodwin WJ, Ferris EJ, Mehta JL.

Curr Opin Cardiol. 2003 Sep;18(5):385-93. Review.

PMID:
12960472
27.

Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors.

Franzmann EJ, Schroeder GL, Goodwin WJ, Weed DT, Fisher P, Lokeshwar VB.

Int J Cancer. 2003 Sep 1;106(3):438-45.

28.

Sentinel node biopsy in oral cavity cancer: correlation with PET scan and immunohistochemistry.

Civantos FJ, Gomez C, Duque C, Pedroso F, Goodwin WJ, Weed DT, Arnold D, Moffat F.

Head Neck. 2003 Jan;25(1):1-9.

PMID:
12478537
29.

Distant metastases from oropharyngeal cancer.

Goodwin WJ.

ORL J Otorhinolaryngol Relat Spec. 2001 Jul-Aug;63(4):222-3. Review.

PMID:
11408817
30.

A novel CD44 v3 isoform is involved in head and neck squamous cell carcinoma progression.

Franzmann EJ, Weed DT, Civantos FJ, Goodwin WJ, Bourguignon LY.

Otolaryngol Head Neck Surg. 2001 Apr;124(4):426-32.

PMID:
11283501
31.

Randomized trial of supplemental beta-carotene to prevent second head and neck cancer.

Mayne ST, Cartmel B, Baum M, Shor-Posner G, Fallon BG, Briskin K, Bean J, Zheng T, Cooper D, Friedman C, Goodwin WJ Jr.

Cancer Res. 2001 Feb 15;61(4):1457-63.

32.

MUC4 (sialomucin complex) expression in salivary gland tumors and squamous cell carcinoma of the upper aerodigestive tract.

Weed DT, Gomez-Fernandez C, Bonfante E, Lee TD, Pacheco J, Carvajal ME, Goodwin WJ, Carraway KL.

Otolaryngol Head Neck Surg. 2001 Feb;124(2):127-41.

PMID:
11226945
33.

Sensory recovery in melolabial flaps used for oral cavity reconstruction.

Civantos FJ, Roth J, Goodwin WJ, Weed DT.

Otolaryngol Head Neck Surg. 2000 Apr;122(4):509-13.

PMID:
10740169
34.
35.

Plasma lycopene concentrations in humans are determined by lycopene intake, plasma cholesterol concentrations and selected demographic factors.

Mayne ST, Cartmel B, Silva F, Kim CS, Fallon BG, Briskin K, Zheng T, Baum M, Shor-Posner G, Goodwin WJ Jr.

J Nutr. 1999 Apr;129(4):849-54.

PMID:
10203560
36.

Giant lipoma of the larynx: a case report and literature review.

Yoskovitch A, Cambronero E, Said S, Whiteman M, Goodwin WJ.

Ear Nose Throat J. 1999 Feb;78(2):122-5; quiz 126-8. Review.

PMID:
10089698
37.

Effect of supplemental beta-carotene on plasma concentrations of carotenoids, retinol, and alpha-tocopherol in humans.

Mayne ST, Cartmel B, Silva F, Kim CS, Fallon BG, Briskin K, Zheng T, Baum M, Shor-Posner G, Goodwin WJ Jr.

Am J Clin Nutr. 1998 Sep;68(3):642-7.

PMID:
9734742
38.

PET and recurrent squamous cell carcinoma of the head and neck: a surgeon's view.

Goodwin WJ.

AJNR Am J Neuroradiol. 1998 Aug;19(7):1197. No abstract available.

39.

Somatostatin receptor expression in Hürthle cell cancer of the thyroid.

Gulec SA, Serafini AN, Sridhar KS, Peker KR, Gupta A, Goodwin WJ, Sfakianakis GN, Moffat FL.

J Nucl Med. 1998 Feb;39(2):243-5.

40.

Hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and mitomycin-C (+/- granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma.

Abitbol AA, Sridhar KS, Lewin AA, Schwade JG, Raub W Jr, Wolfson A, Gonzalez-Angulo C, Adessa A, Goodwin WJ, Markoe AM.

Cancer. 1997 Jul 15;80(2):266-76.

PMID:
9217040
41.

Giant cell reparative granuloma of the maxilla.

Spraggs PD, Roth J, Young-Ramsaran J, Goodwin WJ.

Ear Nose Throat J. 1997 Jul;76(7):445-6, 449.

PMID:
9248137
42.

Use of galeal or pericranial flaps for reconstruction or orbital and eyelid defects.

Tse DT, Goodwin WJ, Johnson T, Gilberg S, Meldrum M.

Arch Ophthalmol. 1997 Jul;115(7):932-7.

PMID:
9230844
43.

Use of the melolabial flap in intraoral reconstruction.

Roth J, Patete M, Goodwin WJ.

Otolaryngol Head Neck Surg. 1996 Jan;114(1):12-7.

PMID:
8570232
44.

Imaging of the postoperative neck with emphasis on surgical flaps and their complications.

Wester DJ, Whiteman ML, Singer S, Bowen BC, Goodwin WJ.

AJR Am J Roentgenol. 1995 Apr;164(4):989-93.

PMID:
7726063
45.

Future Costs of Chimpanzees in U.S. Research Institutions.

Dyke B, Williams-Blangero S, Mamelka PM, Goodwin WJ.

ILAR J. 1995;37(4):193-198. No abstract available.

PMID:
11528040
46.

Surgical anatomy of the glossopharyngeal nerve.

Goodwin WJ Jr, Arnold D, Wachholz J.

Laryngoscope. 1993 Nov;103(11 Pt 1):1302-4. No abstract available.

PMID:
8231586
47.

Nutritional management of the head and neck cancer patient.

Goodwin WJ Jr, Byers PM.

Med Clin North Am. 1993 May;77(3):597-610. Review.

PMID:
8492612
48.

Indium 111-labeled leukocyte scintigraphy in evaluating head and neck infections.

Epstein JS, Ganz WI, Lizak M, Grobman L, Goodwin WJ, Dewanjee MK.

Ann Otol Rhinol Laryngol. 1992 Dec;101(12):961-8.

PMID:
1463295
49.

Indications for open cervical node biopsy in HIV-positive patients.

Burton F, Patete ML, Goodwin WJ Jr.

Otolaryngol Head Neck Surg. 1992 Sep;107(3):367-9.

PMID:
1408219
50.

Reduction of the median mandibulotomy with the fixed mandibular implant.

Sangiacomo TR, Goodwin WJ, Stevens MR.

J Oral Maxillofac Surg. 1992 Mar;50(3):292-6.

PMID:
1542072

Supplemental Content

Loading ...
Support Center